Treatment of cholangiocarcinoma by pGCsiRNA-vascular endothelial growth factor in vivo

CONCLUSIONS: In vivo silencing of VEGF can affect cell survival and inhibit cell migration, invasion, and development, probably by enhancing apoptosis and inhibiting the expressions of MMP2 and MMP9.PMID:38708333 | PMC:PMC11063079 | DOI:10.2478/abm-2024-0009
Source: Biomed Res - Category: Research Authors: Source Type: research